A telemedicine and innovation company has developed and copyrighted a unique medical wearable that puts it at the forefront of the global mIoT (medical Internet of Things) market.

A wearable equipped with biosensors, specialized in evaluating, screening and prioritizing Covid-19 patients with leading computational capability to perform complex Neural Networks without depending on third-party systems or internet connectivity, delivers real-time results without delay and with minimal power consumption.

VIDAVO, has created a valuable tool capable of providing decision support to the physician based on an integrated Clinical Decision Support System (CDSS) and this ambitious perspective of edge computing, which defines the need for the devices around us to gain intelligence and be capable of making decisions, is beginning to take shape in real terms with meaningful and effective use.

Vidavo has been listed on the Athens Stock Exchange (En.A) since 2010 under the code "ΒINTA" and is considered by financial analysts as a rapidly growing company.